About
Activities

Please donate

Please support us
with your donation
Donate here

Member Area
Search
Member Login

Some areas of this website are accessible to registered members only.


If you have no account yet, please click on "Register". If you have forgotten your password, please click on "Forgot login?".

Members Online
None
You are here: Home Virtual Education Program John Goldman: CML Treatment with imatinib

Please click on the video to start the presentation. While watching the presentation, you can also click on each of the small slides to jump to the sections. We appreciate your feedback: Please rate the video with the radio buttons above, share your comments using comments box below, or share your ideas in our Discussion Forum. View the other Virtual Education Program modules.

Issues covered in this presentation:

  • Biology and mechanisms of CML
  • Mechanism of action of imatinib
  • Results of the IRIS study
  • Adverse effects of imatinib
  • Methods to detect residual disease
  • Imatinib in children and in pregnancy

 

Has this been helpful? Please provide your comments here:



Community Builder Avatar
Gilles Cousineau (04.01.2011 (00:06:13))
CML Treatment with imatinib Yes No I am a French Canadian and 57 years old.In June 2005, I started Gleevec. Now, I am currently PCRU.
I adored the presentation of Dr. Goldman. In fact, I saw him at a conference at the Royal Victoria Hospital in Montreal with Dr. Pierre Laneuville. I loved the slideshow because it’s very clear and overall, a good introduction to CML.
I created a website which includes a lot of information on CML which includes links to the various presentations from iCMLf. My Website is at www.CMLeukemia.com.
Quote

 5000 Characters left

Antispam Refresh image Case sensitive

© iCMLf International Chronic Myeloid Leukemia Foundation